Comment on Skyhawk’s latest biopharma collaboration is worth up to $1.8B

Skyhawk’s latest biopharma collaboration is worth up to $1.8B

Skyhawk has also previously unveiled partnerships with the likes of Vertex Pharmaceuticals Inc., Bristol Myers Squibb, Takeda Pharmaceuticals, Genentech and Biogen Inc.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News